Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) active compounds. Its structure allows for effective binding to specific neurotransmitter transporters, making it valuable in creating drugs aimed at treating depression, anxiety, and related psychiatric disorders. The presence of both fluorine and piperazine moieties enhances bioavailability and receptor affinity, contributing to improved pharmacokinetic profiles in final drug formulations. It is also employed in medicinal chemistry research for structure-activity relationship (SAR) studies targeting novel psychotropic agents.